(AROC) AroCell - Performance 28.1% in 12m
Compare AROC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-44.59%
#30 in Group
Rel. Strength
86.84%
#1048 in Universe
Total Return 12m
28.09%
#7 in Group
Total Return 5y
-60.00%
#31 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -2.61%
31th Percentile in Group
12m Total Return: AROC (28.1%) vs XLV (-4.1%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
9.48% | -23.3% | 38.3% | 24.9 | 19.3 | 1.76 | 60.8% | 7.8% |
| RVTY NYSE Revvity |
1.28% | -9.43% | 0.59% | 38.4 | 19.2 | 0.67 | -50.1% | -36.8% |
| QGEN NYSE Qiagen |
8.63% | -1.88% | -1.95% | 113 | 18.1 | 0.99 | -64.4% | -7.5% |
| SHC NASDAQ Sotera Health |
35% | 18% | -47.3% | 138 | 20.2 | 1.68 | -54.5% | -23.6% |
Performance Comparison: AROC vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AROC
| Total Return (including Dividends) | AROC | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 9.62% | 0.87% | 13.81% |
| 3 Months | 3.64% | -7.96% | -6.30% |
| 12 Months | 28.09% | -4.06% | 10.65% |
| 5 Years | -60.00% | 43.49% | 107.77% |
| Trend Score (consistency of price movement) | AROC | XLV | S&P 500 |
| 1 Month | 67.9% | -8.1% | 83% |
| 3 Months | -11.0% | -75.3% | -75.3% |
| 12 Months | 46.4% | -28.8% | 50.1% |
| 5 Years | -80.0% | 89.7% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #15 | 8.67% | -3.69% |
| 3 Month | #8 | 12.6% | 10.6% |
| 12 Month | #7 | 33.5% | 15.8% |
| 5 Years | #32 | -72.1% | -80.8% |
FAQs
Does AROC AroCell outperforms the market?
Yes,
over the last 12 months AROC made 28.09%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months AROC made 3.64%, while XLV made -7.96%.
Over the last 3 months AROC made 3.64%, while XLV made -7.96%.
Performance Comparison AROC vs Indeces and Sectors
AROC vs. Indices AROC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.91% | -4.19% | 21.3% | 17.4% |
| US NASDAQ 100 | QQQ | -4.10% | -7.74% | 21.1% | 16.5% |
| US Dow Jones Industrial 30 | DIA | -4.32% | -0.37% | 21.6% | 20.4% |
| German DAX 40 | DAX | -3.89% | -5.34% | -5.0% | 2.39% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.09% | -2.21% | 20.5% | 20.7% |
| Hongkong Hang Seng | HSI | -7.08% | -10.3% | 12.9% | 14.4% |
| India NIFTY 50 | INDA | 1.01% | 4.78% | 20.8% | 28.3% |
| Brasil Bovespa | EWZ | -4.96% | -7.62% | 12.6% | 36.4% |
AROC vs. Sectors AROC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.55% | -3.79% | 14.2% | 6.53% |
| Consumer Discretionary | XLY | -4.29% | -4.61% | 22.3% | 13.8% |
| Consumer Staples | XLP | -3.05% | 3.03% | 14.3% | 19.0% |
| Energy | XLE | -3.73% | 2.86% | 27.9% | 37.6% |
| Financial | XLF | -5.01% | -3.90% | 14.2% | 5.66% |
| Health Care | XLV | -0.90% | 8.75% | 26.3% | 32.2% |
| Industrial | XLI | -5.60% | -7.20% | 19.8% | 17.1% |
| Materials | XLB | -3.71% | -3.94% | 26.2% | 33.3% |
| Real Estate | XLRE | -2.59% | -1.92% | 20.5% | 12.6% |
| Technology | XLK | -4.99% | -11.6% | 24.2% | 21.0% |
| Utilities | XLU | -3.96% | 0.03% | 13.6% | 10.6% |
| Aerospace & Defense | XAR | -5.89% | -11.5% | 9.77% | 0.76% |
| Biotech | XBI | 2.68% | -2.19% | 41.4% | 40.4% |
| Homebuilder | XHB | -4.38% | -1.86% | 34.5% | 35.6% |
| Retail | XRT | -5.81% | -5.03% | 25.5% | 29.6% |